New Key Statistics Module, Z-Score and F-Score
SHSE:603351 Key Ratios
Market Cap ¥ M | 3,283.05 |
Enterprise Value ¥ M | 3,594.10 |
P/E(ttm) | 24.22 |
PE Ratio without NRI | 25.18 |
Forward PE Ratio | -- |
Price/Book | 2.06 |
Price/Sales | 2.52 |
Price/Free Cash Flow | 25.34 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.31 |
Revenue (TTM) ¥ M | 1,321.00 |
EPS (TTM) ¥ | 1.02 |
Beneish M-Score | -2.15 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -1.30 |
y-y EBITDA Growth Rate % | 53.40 |
EV-to-EBIT | 20.47 |
EV-to-EBITDA | 20.47 |
PEG | -- |
Shares Outstanding M | 135.44 |
Net Margin (%) | 10.42 |
Operating Margin % | 12.68 |
Pre-tax Margin (%) | 12.08 |
Quick Ratio | 0.79 |
Current Ratio | 1.06 |
ROA % (ttm) | 6.02 |
ROE % (ttm) | 8.73 |
ROIC % (ttm) | 6.71 |
Dividend Yield % | 1.24 |
Altman Z-Score | 3.88 |
SHSE:603351 Number of Guru Trades
SHSE:603351 Volume of Guru Trades
Gurus Latest Trades with SHSE:603351
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603351 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nanjing Well Pharmaceutical Group Co Ltd Insider Transactions
No Available Data